Zusammenfassung
Die Zusammenfassung psychotroper Substanzen der verschiedensten chemischen Struktur und Anwendungsformen unter Oberbegriffen erfolgt in diesem Buch in erster Linie im Hinblick auf vergleichbare durch sie ausgelöste psychische Wirkungen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Abel EL (1971) Marihuana and memory: acquisition or retrieval? Science 173: 1038–1040
Abel EL (1976) The scientific study of marihuana. Hall, Chicago
Abelson PH (1968) LSD and marihuana. Science 159: 89–97
Aberle D (1966) The Peyote religion among the Navaho. Aldine, Chicago
Ablon SL, Goodwin FK (1974) High frequency of dysphoric reactions to tetrahydrocannabinol among depressed patients. Am J Psychiatry 131: 448–453
Abood LG, Biel JH (1962) Anticholinerge Psychotomimetica. Int Rev Neurobiol 4: 217–273
Agurell S et al. (1971) Metabolism of 7-hydroxy-delta 1 (16)-THC and CBN. Acta Pharm Suec 8
Agurell S, Dewey WL, Willette RE (eds) (1984) The cannabinoids: chemical, pharmacologic and therapeutic aspects. Academic Press, New York
Akinloye BA, Court WE (1981) The alkaloids of Rauwolfia volksinii. J Ethnopharmacol 4: 99–109
Alpert R (1969) Psychedelics and sexual behavior. J Sex Res 5: 50–54
Amendt G (1974) Haschisch und Sexualität. Enke, Stuttgart
Anderson EF (1969) The biogeography, ecology, and taxonomy of lophophora (cactacea). Brittonia 21 /4: 229–310
Andréasson S, Engström A, Allebeck P, Rydberg U (1988) Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet I I: 1483–1486
Andrews G, Vinkenoog S (eds) (1968) The book of grass. Grove, New York
Angst J (1970) Halluzinogen-Abusus. Schweiz Med Wochenschr 100: 710–715
Angst J, Dittrich A, Woggon B (1972) Psychologische und klinische Aspekte des Cannabismi Bbrauchs. Z Allgemeinmed 48: 94–99
Baker AA, Lukas EG (1969) Some hospital admissions associated with cannabis. Lancet I: 148–160
Barnes C, Fried PA (1974) Tolerance to delta-9-THC in adult rats with differential delta-9THC exposure with immature or during early adulthood. Psychopharmacology (Berlin) 34: 181–190
Battegay R, Bäumler J, Gnirss F, Ladewig D (1969) Zur Drogenabhängigkeit vom Typ Cannabis ( Haschisch, Marihuana). Schweiz Med Wochenschr 99: 965–971
Battersby AR (1963) Recent reasearches on indole alkaloids. Pure Appl Chem 6: 471–488
Bauer W (Hrsg) (1980) Fliegenpilz — Fleisch der Götter, Schamanistische Ekstasekulte in Europa. Trikont, München
Baumgartner AM, Jones PF, Black CT (1981) Detection of phencyclidine in hair. J Forensic Sei 26: 576–581
Baumgartner WA (1986) Analysis of tetrahydrocannabinol (THC) in hair. US-Navy Rehabilitation Center Study, Final Report, pp 1–16
Beaubrun MH, Knight F (1973) Psychiatric assessment of 30 chronic users of cannabis and 30 matched controls. Am J Psychiatry 130: 309–311
Behr H-G (oJ) Haschisch-Kochbuch. Volksverlag, Linden
Behr H-G (1982) von Hanf ist die Rede. Sphinx, Basel
Benitez F (1968) En la tierra mâgica del peyote. Biblioteca Era, Serie Popular, Mexico
Berhardson G, Gunne LM (1972) 46 cases of psychoses in cannabis abusers. Int J Addict 7: 9–16
Beringer K (1927) Der Meskalinrausch. Springer, Berlin (Neudruck 1969 )
Beringer K (1932) Zur Klinik des Haschischrausches. Nervenarzt 5: 30–41
Bialos DS (1970) Adverse marijuana reactions: A critical examination of the literature with selected case material. Am J Psychiatry 127: 819–823
Binder MA (1981) Haschisch und Marihuana — was der Arzt über Cannabinoide wissen sollte. Dtsch Ärztebl 78: 117–120
Bischoff WH (1966) The exstasy drugs. Univ Circle Press, Delray Beach
Blaine JD, Meacham MP, Janowsky DS, Schoor M, Bozetti LP (1976) Pharmacology of marijuana. Raven, New York
Blevins D, Regan JD (1976) Delta-9-THC: Effect on macromolecular synthesis in human and other mammalian cells. In: Nahas GG, Paton WOM, Idänpää-Heikkilä JF (eds) Marihuana: Chemistry, biochemistry, and cellular effects. Springer, New York, pp 32–68
Boettcher C (1866) Über die Anwendung des indischen Hanfes in der Psychiatrie. Berl Klin Wochenschr 3
Bonnie RJ, Whitebread CH (1978) The marihuana conviction. Univ Press of Virginia, Charlottesville
Borg J, Gershon S, Alpert M (1975) Dose effects of smoked marihuana on human cognitive and motor function. Psychopharmacologia 42: 211–218
Boroffka A (1978) Cannabis und Psychiatrie. Suchtgefahren 24: 28–37
Bost RO (1988) 3,4-Methylendioxymethamphetamine (MDMA) and other Amphetamine Derivats. J For Sci 33/2:576–587
Bové FJ (1970) The story of Ergot. Karger, Basel
Bowman M, Pihl R (1973) Cannabis: Psychiological effects of chronic heavy use. Psycho-pharmacology (Berlin) 29: 159–170
Bram S, Bracet P (1976) Inhibition of proliferation and differentation of D. discoideum amoebae by THC and cannabinol. In: Nahas GG, Paton WOM, Idänpää-Heikkilä JF (eds) Marihuana: Chemistry, biochemistry, and cellular effects. Springer, New York, pp 116–138
Braude MC, Szara S (eds) (1976) Pharmacology of marijuana. Raven, New York Brawley P et al. ( 1972 ) Pharmacology of hallucinogens. Pharmacol Rev. 24
Bremkamp S (1980) PCP: Learning to like a dangerous drug. J Psychedelic Drugs 12/2:171–172
Brickenstein R (1971) Gefahren der Cannabisdrogen für Heranwachsende. Z Allgemeinmed 47: 846–851
Bromberg W (1934) Marihuana intoxication. Am J Psychiatry 91: 303–340
Bron B (1979) Psychopathologisches Erscheinungsbild und klinische Bedeutung des Horror-Trips. Suchtgefahren 25 /4: 167–176
Brown FC (1972) Halluzinogenic drugs. Thomas, Springfield/IL
Brunner TF (1977) Marijuana in Ancient Greece and Rome? J Psychedelic Drugs 9 /3: 221–225
Bschor F (1950) Marihuana. Kriminalistik 4: 19–24
Bull J (1971) Cerebral atrophy in young Cannabis smokers. Lancet II: 1420–1448
Burroughs W, Ginsberg A (1964) Auf der Suche nach Yagé. Limes, Wiesbaden
Burstein S, Kupfer D (1971) Hydroxylation of trans-delta-1-THC by hepatic microsomal oxygenase. Ann. NY Acad Sci 191: 32–37
Butler JL, Gaines LS, Lenox JR (1976) Effects of marijuana, expectation and suggestibility on cognitive functioning. Percept Mot Skills 42: 1059–1065
Bye RA Jr (1979) Hallucinogenic plants of the tarahumara. J Ethnopharmacol 1: 23–48
Caldwelle DF et al. (1969) Auditory and visuel threshold effects of marihuana in man. Percept Motor Skills 29: 755–759
Campbell AMG, Evans M, Thomson JLG, Williams MJ (1971) Cerebral atrophy in young cannabis smokers. Lancet II: 1219–1224
Campbell AMG, Evans M, Thomson JLG, Williams MJ (1972) Cerebral atrophy in young cannabis smokers. Lancet I:202 ff.
Carlin AS, Trupin EW (1977) The effect of long-term chronic marijuana use on neuropsychological functioning. Int J Addict 12: 36–48
Carlin AS et al. (1972) Social facilitation of marihuana intoxication. J Abnorm Psychol 80: 132–140
Carlson KA (1979) PCP from the other side. J Psychedelic Drugs 11 /3: 231–238
Cashman J (1968) LSD, die Wunderdroge. Ullstein, Frankfurt am Main
Casswell M (1975) Cannabis and temporal desintegration on experienced and naive subjects. Science 179: 803–805
Casto D (1970) Marijuana and the assassins, an etymological investigation. Br J Addict 65: 219–225
Chait LD, Fischman MW, Schuster CR (1985) “Hangover” effects the morning after marijuhana smoking. Drug Alcohol Depend 15:229–238
Chatterjee A (1953) Rauwolfia alkaloids. Fortschr Chem Organ Naturstoffe 10: 390–394
Cherniak L (1979) The great books of hashish. And/Or Press, Berkeley
Chiang C-W, Barnett G (1984) Marijuana effect and delta-9-tetra-hydrocannabinol plasma level. Clin Pharmacol Ther 36: 234–238
Chopra GS (1973) Studies on psycho-clinical aspects of long-term marihuana use in 124 cases. Int J Addict 8: 1015–1026
Clark LD, Nakashima EN (1968) Experimental studies of marihuana. Am J Psychiatry 125: 379–384
Claussen U, Korte F (1966) Herkunft, Wirkung und Synthese der Inhaltsstoffe des Haschisch. Naturwissenschaften 21: 541–546
Co BT, Goodwin DW, Gado M, Mikhael M, Hill SY (1977) Absence of cerebral atrophy in chronic cannabis users. JAMA 237 /12: 1229–1230
Cohen S (1965) The beyond within — The LSD story. Atheneum, New York
Cohen S (1966) A classification of LSD complications. Psychosomatics 7: 182–186
Cohen S (1982) Cannabis and sex: Multifacted paradoxes. J Psychedelic Drugs 14/1–2: 55–58
Colbach E (1971) Marijuana use by GI’s in Vietnam. Am J Psychiatry 128: 204–207
Coleman JH, Tacker HL, Evans WE, Lemmi H, Britton EL (1976) Neurological manifestations of chronic marihuana intoxication, part 1: Paresis of the fourth cranial nerve. Dis Nery Syst 37: 29–38
Consroe PF, Man DP (1973) Effects of z18- and d9-tetrahydrocannabinol on experimental induced seizures. Life Sci 13: 429–439
Cooper R (1978) A guide to British psilocybin mushrooms. Hassle Free Press
Crawford WJ, Merritt JC (1979) Effects of tetrahydrocannabinol on arterial and intraocular hypertension. Int J Clin Pharmacol Biopharm 17: 191–196
DalCason TA (1989) The characterization of some 3,4-methylenedioxyphenylisopropylamine (MDA) analogs. J For Sci 34 /4: 928–961
Daldrup T, Reudenbach G, Kimm K (1987) Cannabis und Alkohol im Straßenverkehr. Blutalkohol 24: 144–155
Dalterio S, Bartke A (1979) Perinatal exposure to cannabinoids alters male reproductive function in mice. Science 205: 1420–1422
Daunderer M (1979) Therapie einer Atropa-belladonna-Vergiftung mit dem Antidot Physostigmin Med Welt 30: 1743
Davenport J (1966) Aphrodisiacs and love stimulants. Lyle Stuart, New York
Diaz JL (1979) Ethnopharmacology and taxonomy of Mexican psychodysleptic plants. J Psychedelic Drugs 11/1–2: 71–101
Dieckhöfer K, Goenchea S (1972) Zur Toxizität von Cannabis. 1. Mitteilung. Med Welt 23: 779–782
Domino EF (1981) Cannabinoids and the cholinergic system. J Clin Pharmacol [Suppl] 21:149 S-255 S
Don Castro III (1970) Marihuana and the assassins. Br J Addict 65: 35–39
Doorenbos NJ et al. (1971) Cultivation, extraction and analysis of cannabis. Ann NY Acad Sci 191: 90–95
Dornbush RL, Abrams R, Fink M (1971) Marijuana, memory and perception. Am J Psychiatry 128: 194–197
Dowling GP, McDonough ET, Bost RO (1987) „Ere“ and „Ecstasy”. A report of five deaths associated with the use of MDEA and MDMA. JAMA 257/12:1615–1617
Eberle P (1973) Verursachen Halluzinogene Chromosomendefekte und Mißbildungen? Nervenarzt 44: 281–284
Edery H, Soroko D, Kunberg W (1971) Structural requirements for cannabinoid activity. Ann NY Sci 191: 139–145
Efron DH (1970) Psychotomimetic drugs. Raven, New York
Efron D, Holmstedt B, Kline NS (eds) (1967) Ethnopharmacological search for psychoactive drugs. Public Health Sery Publ 1645: 211–216
Eliade M (1956) Schamanismus und archaische Ekstasetechnik. Rascher, Zürich Stuttgart
Estrada A (1980) Maria Sabina, Botin der heiligen Pilze. Trikont, München
Eugster CH (1968) Wirkstoffe aus dem Fliegenpilz. Naturwissenschaften 55: 305–313
Farnsworth NR (1968) Hallucinogenic plants. Science 162: 96–105
Feldman HW et al. (eds) (1979) Angel dust: An ethnographic study of PCP users. Lexington Books, Lexington/MA
Feuerlein W (Hrsg) (1980) Cannabis heute, Bestandsaufnahme zum Haschischproblem. Akademische Verlagsgesellschaft, Wiesbaden
Fink DJ, Ashworth B, Brewer C (1972) Cerebral atrophy in young cannabis smokers. Lancet I: 143–147
Fisher G, Steckler A (1974) Psychological effects, personality and behavioral changes attributed to marihuana use. Int J Addict 9: 101–126
Fligiel SEG, Venkat H, Gong H, Tashkin DP (1988) Bronchial pathology in chronic marijua- na smokers: a light and electron microscopic study. J Psychoactive Drugs 20: 33–42
Franks HM, Starmer GA, Chesher GB, Jackson DM, Hensley VR, Hensley WJ (1975) The interaction of alcohol and delta-9-tetrahydrocannabinol in man. Effects on psychomotor skills related to driving. Add. Res. Fornd. of Ontario, Toronto
Frederking W (1955) LSD-25 and mescaline in psychotherapy. J Ment Dis 121: 70–77
Freedman DX (1963) Psychotomimetic drugs and brain biogenic amines. Am J Psychiatry 119: 843–850
Fried PA (1977) Behavioral and electroencephalographic correlates of the chronic use of marihuana — a review. Bull Narc 29 /2: 29–34
Friedberg C (1965) Des Banisteriopsis utilisés comme drogue en Amérique du sud. J Agric Trop Bot Appl 12:403–437, 550–594, 729–780
Furst PT (1971) Ariocarpus retusus, the “false peyote” of Huichol tradition. Econ Bot 25 /1: 182–187
Furst PT (ed) (1972) Flesh of the gods: The ritual uses of hallucinogens. Prager, New York Furst PT (1976) Hallucinogens and culture. Chandler & Sharp, San Francisco
Galanter M, Wyatt R, Lemberger L, et al. (1972) Marijuana intoxication: Interaction between physiologic effects and subjective experience. Science 176: 934–936
Gale EN, Guenther G (1971) Motivational factors associated with the use of cannabis. Br J Addict 13: 30–36
Gaoni Y, Mechoulam R (1964) Isolation, Structure and partial synthesis of an active constituent of hashish. J Am Chem Sci 86: 136–147
Gautier T (1846) Le club des hachichins. Revue des Deux Mondes
Gerlach D, Schilling S (1984) Phencyclidin, Hinweise zur Erkennung und Behandlung von PCP-Intoxikationen. Suchtgefahren 30: 273–279
Gielsdorf W, Klug E (1981) Neues Rauschmittel auf dem Drogenmarkt: 2,5-Dimethoxy-4bromamphetamin ( DOB ). Dtsch Apoth Z 20: 1003–1005
Gilmour DG, Bloom AD, Kusum PL, Robbins ES, Maximilian C (1971) Chromosomal aberrations in users of psychoactive drugs. Arch Gen Psychiatry 24: 268–272
Goenchea S, Dieckhöfer K (1972) Zur Toxizität von Cannabis, 2. Mitteilung. Med Welt 23: 1148–1151
Goode E (1970) The marijuana smokers. Basic, New York
Gorman M, Neuss N, Cone NJ (1965) Vinca alkalois, XVII. Chemistry of catharanthine. J Am Chem Soc 87: 93
Gostomzyk JG, Parade P, Gewecke H (1973) RauschmittelgenuB und Leistungsfähigkeit ( Untersuchungen zur Energiebildung unter Haschisch ). Z Rechtsmed 73: 131–136
Green GS (1984) Discussion of the use of marihuana, ethanol, and other drugs among drivers killed in single vehicle crashes. J Forensic Sci 29: 16–21
Grinker RR (1964) Bootlegged ecstasy. JAMA 187: 768
Grinspoon L, Bakalar JB (1981) Psychedelic drugs reconsidered. Basic, New York Grof S ( 1983 ) LSD-Psychotherapie. Klett-Cotta, Stuttgart
Gröger D (1966) Fortschritte der Chemie und Biochemie der Mutterkornalkaloide. Fortschr Chem Forsch 6: 159–164
Gross D (1971) Vorkommen, Struktur und Biosynthese natürlicher Piperidinverbindungen. Fortschr Chem Org Naturstoffe 29: 1–18
Gruenwaldt G (1971) Haschisch, Marihuana, LSD — Eigenschaften, Bedeutung, Gefahren. Saari Ärztebl 24: 33–37
Grupp SE (1972) Multiple drug use in a sample of experienced marijuana smokers. Int J Addict 7: 481–491
Haenel TA (1970) Kulturgeschichte und heutige Problematik des Haschischs. Pharmakopsychiat Neuropsychopharmakol 3: 89–115
Hai H (1984) Das Hanfhandbuch. Piper, Löhrbach ( Der grüne Zweig, Bd 73 )
Halikas JA, Goodwin DW, Guze SB (1972) Marihuana use and psychiatric illness. Arch Gen Psychiatry 27: 162–165
Hallucinogenic and Psychedelic Drug Synthesis Manual (1976) Salt and Pepper Syndicate. Lawrence/KS
Harding R, Knight F (1973) Marihuana-modified mania. Arch Gen Psychiatry 29: 635–637
Harner MJ (ed) (1973) Hallucinogens and shamanism. Oxford Univ Press, London
Harvey DJ (1985) Marihuana 1984. IRL Press, Oxford
Harzer K (1982) Nachweis von LSD in Körperflüssigkeiten mit Hochleistungsflüssigkeitschromatographie. J Chromatogr 249: 205–211
Hasse HE, Waldmann H (1971) „Flashback“: Spontane psychotische Episoden als Folgeerscheinung des Phantasticagebrauchs Jugendlicher. Arch Psychiatr Nervenkr 214:399–439
Hawkes JG et al. (ed) (1979) The biology and taxonomy of the solonaceae. Academic Press, London
Heath RG (1976) Marihuana and delta 9 tetrahydrocannabinol: Acute and chronic effects on brain function of monkeys. In: Braude MC, Szara S (eds) Pharmacology of marihuana. Raven, New York, pp 345–356
Heath RG, Fitzjarrell AT, Garey RE, Myers WA (1979) Chronic marihuana smoking: Its effects on function and structure of the primate brain. In: Nahas GG, Paton WDM (eds) Marihuana: Biological effects. Pergamon, New York, pp 713–730
Heim R (1967) Nouvelles investigations sur les champignons hallucinogènes. Editions des Musées Nationaux Histoire Paris
Heim R, Wasson RG (1958) Les champignons hallucinogènes du Mexique. Editions des Musées Nationaux Histoire, Paris
Heinemann C (1973) Nachlassende Wirkung initialer Rauscherlebnisse und Dosisteigerung beim Haschischkonsumenten. Med Klin 68: 826–830
Helmer R, Wunder R, Zellmann K, Haesen D (1972) Experimentelle Untersuchungen zur Fahrtüchtigkeit nach Einnahme von Haschisch. Blutalkohol 4: 213–220
Henderson GL (1988) Designer drugs, past history and future prospects. J For Sci 33 /2: 569–575
Henderson RL, Tennant FS, Guerry R (1972) Respiratory manifestations of hashish smoking. Arch Otolaryngol 95: 248–251
Heper RS, Frank IM (1971) Marihuana smoking and intraocular pressure. JAMA 217: 1392
Herha J (1974) Haschisch und Marihuana — eine Übersicht. Naturwissenschaften 61: 90–94
Herning RI, Jones RT, Peltzman DJ (1979) Changes in human event relate potentials with prolonged delta-9-tetrahydrocannabinol ( THC) use. Electroencephalogr Clin Neurophysiol 47: 556–570
Hesse M (1964/1968) Indolalkaloide in Tabellen. Springer, Berlin Heidelberg New York Hesse M (1974) Progress in mass spectrometry, vol 1: Indolalkaloide. Verlag Chemie, Weinheim
Hingson R, Alpert JS, Day N et al. (1982) Effects of maternal drinking and marihuana use on fetal growth and development. Pediatrics 70: 539–546
Hirschhorn K, Cohen MM (1968) Drug-induced chromosomal aberrations. Ann NY Acad Sci 151: 977–987
Hochman JS, Brill NQ (1973) Chronic marijuana use and psychosocial adaption. Am J Psychiatry 130: 132–139
Hoffer A, Osmond H (1967) The hallucinogens. Academic Press, New York
Hoffman D, Brunnemann KD, Gori GB, Wynder EL (1975) On the carcinogenicity of marihuana smoke. Res Adv Phytochem 9: 63–81
Hofmann A (1954) Die Isolierung weiterer Alkaloide aus Rauwolfia serpentina Benth. Heiv Chim Acta 37: 849–865
Hofmann A (1960 a) Psychotomimetica, eine Übersicht. Svensk Kern Tidskr 72:79–88
Hofmann A (1960 b) Die psychotropen Wirkstoffe der mexikanischen Zauberpilze. Chimia 14:309–318
Hofmann A (1961) Die Wirkstoffe der mexikanischen Zauberdroge Ololiuqui. Planta Med 9: 354–367
Hofman A (1964) Die Mutterkornalkaloide. Enke, Stuttgart
Hofmann A (1967) Psychoaktive Stoffe der Pflanzen. Therapiewoche 35: 40–47
Hofmann A (1979) LSD — mein Sorgenkind. Klett-Cotta, Stuttgart
Hofmann A (1981) LSD ist eine sakrale Droge (Interview mit Dr. Hofmann). Psychol Heute 4: 55–61
Hofmann A, Tscherter H (1960) Isolierung von Lysergsäurealkaloiden aus der mexikanischen Zauberdroge Ololiuqui. Experimentia XVI /9
Hole G (1967) LSD und verwandte Halluzinogene. Geschichte — Wirkung — Gebrauch und Gefahren. MMW 109: 1389–1397
Hollister LE (1968) Chemical psychoses. LSD and related drugs. Thomas, Springfield/IL
Hollister LE, Richards RK, Gillespie HK (1968) Comparison of tetrahydrocannabinol and synhexyl in man. Clin Pharmacol Ther 9: 783–791
Honecker HC, Coper C (1970) Dünnschichtchromatographische Nachweismethode von Opium als Beimengung in Haschisch-Proben. Dtsch Med Wochenschr 42: 441–443
Huxley A (1972) The doors of perception. (dtsch. Übers: Die Pforten der Wahrnehmung. Piper, München )
Isbell H, Gorodetzky CW, Jasinsky D, Claussen U, Spulak F, Korte F (1967) Effects of (—)-delta-9-transtetrahydrocannabinol in man. Psychopharmacologia (Berlin) 11: 184–188
Jacobson CB, Berlin CM (1972) Possible reproductive detriment in LSD users. JAMA 222:1367–1373
Jakubovic A, McGeer D (1972) Inhibition of rat brain protein by cannabinoids in vitro. Can J Biochem 50: 654–660
Janowsky DS, Meacham MP, Blaine JD, Schoor M, Bozetti LP (1976) Simulated flying performance after marihuana intoxication. Aviat Space Environ Med 47: 124–128
Johnson S, Domino EF (1971) Some cardiovascular effects of marihuana smoking in normal volunteers. Therapeutics 12: 762–768
Jones H, Jones HC (1977) Sensual drugs. Cambridge Univ Press, Cambridge Jones HC, Lovinger PW ( 1985 ) The marijuana question. Mead, New York
Jones R (1977) Human effects. NIDA Res Monogr 14: 128–178
Joyce CRB, Curry SH (1970) The botany and chemistry of cannabis. Churchill, London
Kaiser C, Gold R (1974) Perception, psychedelics and social change. J Psychedelic Drugs 6: 30–35
Kaplan HS (1971) Psychosis associates with marijuana. NY State J Med 71: 433–435
Karler R (1977) Toxicological and pharmacological effects. NIDA Res Monogr 14: 55–66
Karler R, Cely W, Turkanis SA (1974 a) Anticonvulsant properties of 4 9 -tetrahydrocannabinol and other cannabinoids. Life Sci 15: 931–947
Karler R, Cely W, Turkanis SA (1974b) A study of the development of tolerance to an anticonvulsant effect of delta-9-THC and cannabidiol. Res Commun Chem Pathol Pharmacol 9: 23–29
Kaymakcalan S (1975) Potential dangers of cannabis. Int J Addict 10: 721–735
Keller K, Stahl E (1982) Kalmus: Inhaltsstoffe und Asarongehalt bei verschiedenen Herkünften. Dtsch Apoth Z 122 /48: 2463–2466
Kennedy AB, Rätsch C (1985) Datura: Aphrodisiac? High Frontiers, Berkeley
Keup W (1967) Psychotic symptoms due to cannabis abuse (a survey of newly admitted mental patients). Dis Nerv Syst 31: 119–126
Kielholz P, Hobi V, Ladewig D, Miest P, Richter R (1973) An experimental investigation about the effect of cannabis on car absorption. Pharmakopsychiatry 6: 91–103
Klonoff H (1983) Acute psychological effects of marihuana in man, including acute cognitive, psychomotor, and perceptual effects on driving. In: Fehr O’Brien K, Kalant H (eds) Cannabis and health hazards. Addiction Research Foundation, Toronto, pp 88–96
Klonoff H, Low MD (1974) Psychological and neurophysiological effects of marihuana in man- An interaction model. In: Miller LL (ed) Marihuana: Effects on human behavior. Academic Press, New York, pp 359–397
Knecht S (1962) Magische Pilze. Über die mexikanische Pilzzeremonie. Med Welt 35: 1853–1859
Koch CAL (1864) Der Hanf. Allg Z Psychiatr 21: 13–19
Kolansky H, Moore WT (1971) Effects of marihuana on adolescents and young adults. JAMA 216: 486–492
Konzett H (1981) Halluzinogene: LSD, Psilocybin und Mescalin. Dtsch Ärztebl 78: 283–288
Korte F et al. (1965) THC-Carbonsäure, ein neuer Haschisch-Inhaltsstoff. Angew Chem 77
Krumsick L (1975) Haschischöl. Kriminalistik 3: 124–128
Kuehne ME (1964) The total synthesis of vincamine. J Am Chem Soc 86: 2946–2973
Kuehnle J, Mendelson JH, Davis DR, New PFJ (1977) Computed tomographic examination of heavy marihuana smokers. JAMA 237 /12: 1231–1232
Kumar S, Kunwar KB (1972) Chromosome abnormalities in cannabis addicts. J Assoc Phys India 19: 193–195
Kutney JP, Brown RT, Piers E (1966) The absolute configuration of the Iboga alkaloids. Can J Chem 44: 637–645
Kvalseth TO (1977) Effects of marijuana on human reaction time and motor control. Percept Mot Skills 45: 935–939
LaBarre W (1960) Twenty years of peyote studies. Curr Anthropol 1: 45–60
LaBarre W (1972) Hallucinogens and the shamanic origins of religion. In: Furst PT (ed) Flesh of the Gods: The ritual usees of hallucinogens. Praeger, New York, pp 36–49
La Valle S (1984) Hashish. Quarter Books, London New York Melbourne
Leaf RC, De Bold RC (1967) LSD, man and society. Wesleyan Univ Press, Connecticut
Leary T (1962) How to change behaviour. (Proceedings of X IV. International Congress on Applied Psychology, Copenhagen )
Leary T (1964) The religious experience. Psychedelic Rev 3: 30–42
Leary T (1970) Politik der Ekstase. Wegner, Hamburg
Leistenfels H von (oJ) Pilze: Speisepilz-Zucht Rauschpilz-Erkennung. Pieper & Die Grüne Kraft, Löhrbach (Grüner Zweig, Bd 65)
Leonhardt RW (1970) Haschischreport. Piper, München
Leuenburger H (1969) Zauberdrogen. Goverts, Stuttgart
Leuner H (1971) Halluzinogene in der Psychotherapie. Pharmakopsychiatry 4: 333–351
Leuner H (1981) Halluzinogene. Huber, Bern
Levy JA, Munson AE, Harris LS, Dewey WL (1975) Effects of delta-9-THC on the immune response of mice. Fed Proc 34: 782–789
Lewin L ( 1927, 1981 ) Phantastica — Die betäubenden und erregenden Genußmittel. Volksverlag, Linden
Lewin L (1929) Banisteria Caapi. Stilke, Berlin
Lewis EG, Peters BA, Dustman RE, Straight RC, Beck EC (1976) Sensory, perceptual, motor and cognitive functioning and subjective reports following oral administration of delta-9-THC. Psychopharmacologia (Berlin) 47: 141–148
Lidz T, Rothenberg A (1970) Psychedelismus: Die Wiedergeburt des Dionysos. Psyche 24: 359–374
Lockwood TE (1979) The ethnobotany of brugmansia. J Ethnopharmacol 1: 147–164
Ludlow FH (1981) Der Haschisch-Esser. Sphinx, Basel
Madsen W (1955) Shamanism in Mexico. Southwest J Anthropol 2 /1: 48–57
Manno JE, Kiplinger GF, Haine SE, Bennett IF, Forney RB (1970) Comparative effects of smoking marihuana or placebo on human motor and mental performance Clin Pharmacol Ther 11: 808–815
Margolis JS, Clorfene R (1979) Der Grassgarten. Volksverlag, Linden
Marijuana and Health (1980) 8th Annual Report to the US Congress from the Secretary of Health, Education and Welfare, Washington/DC
Marijuana and Health (1985) Report of a study be the committee of the Institute of Medicine. National Academic Press, Washington/DC
Marzell H (1964) Zauberpflanzen — Hexengetränke. Kosmos 241: 47–55
Mason AP, McBay AJ (1984) Ethanol, marijuana, and other drugs use in 600 drivers killed in single-vehicle crashes in North Carolina, 1978–1981. J Forensic Sci 29: 987–1026
Mason AP, McBay AJ (1985) Cannabis: Pharmacology and interpretation of effects. J Forensic Sci 30: 615–631
McBay AJ (1985) Marijuana testing and litigation. J Forensic Sci 30: 987–994
McGlothlin WS, Cohen S, McGlothlin M (1964) Short-term effects of LSD on anxiety, attitudes and performance. J Nery Ment Dis 139: 266–273
McGlothlin WS, Cohen S, McGlothlin M (1970) Long lasting effects of LSD on normals. J Psychedelic Drugs 3: 20–31
McLeary JA, Sypherd PS, Walkington DL (1960) Antibiotic activity of an extract of peyote Lophophora williamsii ( Lemaire) Coulter. Econ Bot 14: 247–249
Mechoulam R (1970) Marihuana chemistry. Science 168: 1159–1166
Mechoulam R (1973) Marihuana- Chemistry, pharmacology, metabolism and clinical effects. Academic Press, London
Mechoulam R, Gaoni Y (1965) A total synthesis of d,l -delta-tetrahydrocannabinol, the active constituent of hashish. J Am Chem Soc 87: 3273–3275
Meck B (1981) Die Assassinen. Econ, Düsseldorf Wien
Melges FT, Tinklenberg JR, Hollister LE, Gillespie HK (1970) Marihuana and temporal disintegration. Science 6: 1118–1120
Mendelson JH (ed) (1974) The use of marihuana. Plenum, New York
Mendelson JH (1987) Marijuana. In: Meltzer HY (ed) Psychopharmacology. Raven, New York, pp 60–67
Mendelson JH, Rossi AM, Meyer RE (eds) (1974) The use of marihuana; a psychological and physiological inquiry. Plenum, New York
Merkus F et al. (1971) TLC, GLC and MS of cannabidivarin, tetrahydrocannabivarin and cannabivarin. Acta Pharm Suec 8
Miller LL (ed) (1974) Marijuana — effects on human behavior. Academic Press New York San Fransisco London
Miller RA (1983) The magical and ritual use of herbs. Destiny, New York
Morton JF (1981) Atlas of medical plants of middel america. Thomas, Springfield/IL
Moskowitz H, McGlothlin WS (1974) Effects of marihuana on auditory signal detection. Psychopharmacologia (Berlin) 48: 159–163
Myerhoff BG (1980) Der Peyote Kult. Trikont, München
Nahas GG (1972) Toxicology and pharmacology of cannabis sativa with special reference to delta-9-THC. Bull Narc 24: 11–27
Nahas GG (1974) Effects of cannabis and cannabinoids on cell replication and replication and DNA synthesis in man. J Pharmacol 5: 71–78
Nahas GG (1979) Keep off the grass. Pergamon, Oxford New York
Nahas GG (1982) Hashish in Islam, 9th to 18th century. Bull NY Acad Med 58 /9: 814–831
Nahas GG (ed) (1984) Marihuana in science and medicine. Raven, New York
Nahas GG (1986) Cannabis: toxicological properties and epidemiological aspects. Med J Aust 145: 82–87
Nahas GG, Patton WDM (eds) (1979) Marihuana: Biological effects — analysis, metabolism, cellular responses, reproduction and brain. Pergamon, Oxford
Nahas GG, Sucia-Foca N, Armand J-P, Morishima A (1974) Inhibition of cellular mediated immunity in marihuana smokers. Science 183: 419–420
Nahas GG, Desoize B, Hsu J, Morishima A, Srinivasan PR ( 1975 a) Inhibition of nucleic acid and proteins synthesis by natural cannabinoids and olivetol. (Abstract IV. Int. Congress of Pharmacology, Helsinki, p 495 )
Nahas GG, Desoize B, Hso J, Morishima A, Srinivasan PR ( 1975 b) Inhibition of nucleic acid and proteins synthesis by natural cannabinoids and olivetol. (Abstract V I. Int. Congress of Pharmacology, Helsinki )
Nahas GG, Paton WDM, Idänpään-Heikkilä JE (eds) (1976) Marihuana: chemistry, biochemistry and cellular effects. Springer, New York
Negrete JC (1973) Psychological adverse effects of cannabis smoking: A tentative classification. Can Med Assoc J 108: 195–196
Neu RL, Powes HO, King S, Gardner LI (1969) Cannabis and chromosomes. Lancet I: 675
Neumeyer JL, Shagoury L (1971) Chemistry and pharmacology of marijuana. J Pharm Sci 60:1433–1451
Nichols WW, Miller RC, Heneen W, Bradt C, Hollister L, Kanter S (1974) Cytogenetic studies on human subjects receiving marihuana and delta-9-tetrahydrocannabinol. Mutat Res 26: 413–417
Novotny M, Lee MC, Keast D (1976) A possible chemical basis for the higher mutagenicity of marihuana smoke as compared to tobacco smoke. Experientia 32: 280–282
Nowlan R, Cohen S (1977) Tolerance to marihuana: heart rate and subjective “high”. Clin Pharmacol Ther 22: 550–555
Ohlsson A, Lindgren JE, Wahlen A et al. (1980) Plasma delta-9-tetrahydrocannabinol concentrations and clinic effects after oral and intravenous administration and smoking. Clin Pharmacol Ther 28: 409–416
Olvedi U (1972) LSD-Report. Suhrkamp, Frankfurt am Main
Orzechowski G (1969) Halluzinogene Drogen. Med Welt 16: 955–963
Oss OT, Oeric ON (1976) Psilocybin, magic mushrooms grower’s guide. And/Or Press, Berkeley
Ott J (1976) Hallucinogenic plants of North America. Wingbow, Berkeley/CA
Ott J, Bigwood J (ed) (1978) Teonanacatl: Hallucinogenic mushrooms of North America. Madrona, Seattle/WA
Pace HD, Davis A, Borgen LA (1971) Teratogenesia and marihuana. Ann NY Acid Sci 191: 123–128
Pahnke W (1963) Drugs and mysticism: An analysis of the relationship between psychedelic drugs and the mystical consciousness. Master’s thesis Univ of Harvard
Petersen BH, Graham J, Lemberger L (1976) Marihuana, tetrahydrocannabinol and T-cell function. Life Sci 19: 395–400
Petersen RC (ed) (1977) Marihuana research findings. NIDA Res Monogr 14: 205–218
Petersen RC (ed) (1980) Marijuana research findings. NIDA Res Monogr 31: 69–85
Petersen RC, Stillman RC (1978) Phencyclidine ( PCP) abuse: An appraisal. NIDA Res Monogr 21: 168–175
Petrzilka T, Haefliger W, Sikemeier G, Ohloff G, Eschenmoser A (1967) Synthese und Chiralität des (—)-Cannabidiols. Helv Chim Acta 50: 719–723
Peuckert W-E (1960) Hexensalben. Med Monatsspiegel 9: 169–174
Pope HG Jr (1969) Tabernanthe iboga — an African narcotic plant of social importance. Econ. Bot 23: 174–184
Raffauf RF, Flagler MB (1960) Alkaloids of the apocynaceae. Econ Bot 14: 37–46
Ranke-Graves R von (1985) Griechische Mythologie. Rowohlt, Reinbek
Ray R, Prabhu GG, Mohan D, Nath LM, Neki JS (1978) Cannabis use. The association between chronic cannabis abuse and cognitive functions. Drug Alcohol Dep 3: 365–368
Rayner R (1979) Pilze erkennen — leicht gemacht. Franckh’sche Verlagshandlung, Stuttgart Reed A, Kane W (1972) Phencyclidine (PCP). J Psychedelic Drugs 5 /1: 8–12
Reeve VC, Grant JD, Robertson W et al. (1983 a) Plasma concentration of delta-9-tetrahydrocannabinol and impaired motor function. Drug Alcohol Dep 11: 167–175
Reeve VC, Robertson WB, Grant J et al. (1983b) Hemolyzed blood and serum levels of 49-THC: Effects on the performance of roadside sobriety tests. J Forensic Sci 28: 963–971
Remschmidt H (1972) Haschisch und LSD. Physische und psychische Wirkungen. Med Klin 67:706–716, 781–786
Renault PF, Schuster CR, Heinrich R, Freeman DX (1971) Marihuana: Standartized smoke administration and dose effects surves on heart rate in humans. Science 174: 589–591
Ricklin F (1989) Cannabis: harmloses Rauschgift? Schweiz Med Wochenschr 119:1173–1176
Rivier L, Lindgren J-E (1972) Ayahuasca — South American hallucinogenic drink: ethnobotanical and chemical investigations. Econ Bot 24: 100–129
Rodin E, Domino E, Porzak J (1970) The marijuana induced social high — Neurological and electroencephalographic concomitants. JAMA 213: 1300–1302
Rosenthal E (1984) Marijuana beer. And/Or Press, Berkeley
Safford WE (1916) Identity of cohoba, the narcotic snuff of ancient Haiti. J Wash Acad Sci 6: 548–562
Sahihi A (1989) Designer-Drogen: die neue Gefahr. Beltz, Weinheim Basel
Sallan SE, Zinberg NE, Frei E (1975) Antimetic effect of delta-9-THC in patients receiving cancer chemotherapy. N Engl J Med 293: 795–797
Sankar DVS (1975) LSD — A total study. PJD Publications, Westbury/NY
Sankar DVS, Roszy PW, Geisler A (1969) Chromosome breakage in childern treated with LSD-25 and UML-491. Compr Psychiatry 10: 406–410
Saxton JE (1956) The indole alkaloids excluding harmine and strychnine. Q Rev 10: 108–112
Schleifer H (1973) Sacred narcotic plants of the New World Indians. Hafner, New York
Schmiechen R et al. (1986) Carbolines — A new class of compounds with high affinity for benzodiazepine receptors. (Sonderdruck: IXth International Symposium on Medicinal Chemistry, Berlin )
Schönhofer PS (1973) Die Pharmakologie der Cannabis-Wirkstoffe. Arzneimittelforsch 23: 50–55
Schultes RE (1941) A contribution to our knowledge of rivea corymbosa, the narcotic ololiuqui of the Aztecs. Harvard Botanical Museum, Cambridge/MA
Schultes RE (1969) Hallucinogens of plant origin. Science 163: 245–254
Schultes RE (1969/1970) The plant kingdom and hallucinogens. Bull Narc 21: 3–16, 22: 2553
Schultes RE (1970 a) The botanical and chemical distribution of hallucinogens. Ann Rev Plant Physiol 21:571–590
Schultes RE ( 1970 b) Botany and chemistry of cannabis. Churchill, London
Schultes RE (1972) An overview of hallucinogens in the western hemisphere. In: Furst PT (ed) Flesh of the Gods: The ritual uses of hallucinogens. Praeger, New York, pp 3–54
Schultes RE (1976) Hallucinogenic plants. Golden Press, New York
Schultes RE, Hofmann A ( 1980 a) The botany and chemistry of hallucinogens. Thomas, Springfield/IL
Schultes RE, Hofman A ( 1980 b) Pflanzen der Götter. Die magischen Kräfte der Rausch-und Giftgewächse. Hallwag, Bern Stuttgart
Schultz 0E, Haffner C (1958) Zur Kenntnis eines sedativen Wirkstoffes aus dem deutschen Faserhanf. Arch Pharm (Berlin) 291: 20–24
Schurz J (1970) Vom Bilsenkraut zum LSD. Franksche Verlagshandlung, Stuttgart
Schwarz CJ (1968) The complications of LSD: a review of the literature. J Nerv Ment Dis 146: 174–186
Sharma S, Moskowitz H (1972) Effect of marihuana on the visual autokinetic phenomenon. Percept Mot Skills 35: 891–894
Silverman J (1968) Shamans and acute schizophrenia. Am Anthropol 69: 21–31
Smith MV (1981) Psychedelic chemistry. Loompanics Unlimited Mason/USA (Nachdruck des 1973 in Rip Off Press erschienenen Werkes)
Soueif MI (1976) Differential association between chronic cannabis use and brain function deficits. Ann NY Acad Sci 282: 323–343
Stafford P (1980) Enzyklopädie der psychedelischen Drogen. Volksverlag, Linden Stahl E et al. ( 1978 ) Rauschgiftpilze mit LSD. Arch Krim, S 162
Stanton MD, Mintz J, Franklin RM (1976) Drug flashbacks. II. Some additional findings. Int J Addict 11: 53–69
Starks M (1979) Marijuana potency. And/Or Press, Berkeley
Steckel R (oJ) Bewußtseinserweiternde Drogen. Haschisch-Marihuana-LSD-MeskalinSTP(DOM)-Psilocybin-Ololiuqui. Edition Voltaire
Stefanis C, Dornbush R, Fink M (1977) Hashish-studies of long-term use. Raven, New York
Stenchever MA, Kunysz TJ, Allen MA (1974) Chromosome breakage in users of marihuana. Am J Obstet Gynecol 118: 106–113
Stoll WA (1947) Lysergsäureamid, ein Phantastikum aus der Mutterkorngruppe. Schweiz Arch Neurol Psychiatr 60: 279–323
Stoll WA (1952) Recent investigations on ergot alkaloids. Fortschr Chem Org Naturst 9: 114119
Stowe BB (1959) Occurence and metabolism of simple indoles in plants. Fortschr Chem Org Naturst 17: 248–252
Stringaris MG (1972) Die Haschischsucht. Springer, Berlin Heidelberg New York
Stromberg VL (1954) The isolation of bufotenin from Piptadenia peregrina. J Am Chem Soc 76: 170–171
Svrcek M (1979) Der Kosmos-Pilzführer. Franckh’sche Verlagshandlung, Stuttgart Täschner K-L (1980) Haschisch für alle. Hess. Ärztebl 7 (Sonderdruck)
Täschner K-L (1981) Das Haschischproblem aus klinischer Sicht. Dtsch Ärztebl 78: 126–129
Täschner K-L (1983) Zur Psychopathologie und Differentialdiagnose sogenannter Cannabispsychosen. Fortschr Neurol Psychiatr 51: 235–248
Täschner K-L (1986) Das Cannabisproblem — Haschisch und seine Wirkungen. Deutscher Ärzteverlag, Köln
Täschner K-L, FrieBem DH (1989) Verkehrstauglichkeit bei Rauschgiftkonsumenten unter besonderer Berücksichtigung des CannabismiBbrauchs. Suchtgefahren 35:253–262 (Sonderdruck)
Täschner K-L, Wanke K (1975) Zur Frage der toxischen Psychose am Beispiel der sog. LSD-Psychose. Fortschr Med 31: 1515–1518, 1542
Tarshis MS (1972) The LSD controversy — an overview. Thomas, Springfield/IL
Tashkin DP, Simmons M, Clark V (1988) Effect of habitual smoking of marijuana alone and with tobacco on nonspecific airways hyperreactivity. J Psychoactive Drugs 20: 21–25
Taylor FM (1988) Marijuana as a potential respiratory tract carcinogen: a retrospective analysis of a community hospital population. South Med J 81: 1213–1216
Taylor WI (1966) Indole alkaloids, an introduction to the enamine chemistry of natural products. Pergamon, New York
Tennant FS, Groesbeck CT (1972) Psychiatric effects of Hashish. Arch Gen Psychiatry 27: 133–136
Tennant FS, Preble M, Prendergast TJ, Ventry P (1971) Medical manifestations associated with Hashish. JAMA 216: 1965–1969
Thomas WR, Holt PG, Keast D (1974) Recovery of immune system after cigarette smoking. Nature 248: 358–359
Treffert DA (1978) Marihuana use in schizophrenia: a clear hazard. Am J Psychiatry 135: 1213–1215
Ungerleider JT et al. (1968) The “bad trip” — the etiology of the adverse LSD reaction. Am J Psychiatry 124: 1483–1490
Vierth G (1967) Psycho-pathologische Syndrome nach HaschischgenuB. MMW 1: 522–528
Vogel R, Matthiessen W, Bruckner O, Alexander M (1981) Lungenkomplikationen bei Rauschgiftsucht. Prax Pneumol 35:988–991
Völger G (Hrsg) (1982) Rausch und Realität, Drogen im Kulturvergleich, Bd 1–3. Rowohlt, Reinbek (Materialienband zur Ausstellung des Rautenstrauch-Joest-Museums für Völkerkunde der Stadt Köln 1981, Teil 1 und 2 )
Waser P (1971) Pharmakologische Wirkungsspektren von Halluzinogenen. Bull Schweiz Akad Med Wiss 27: 39–57
Wasson RG (1959) The hallucinogenic mushrooms of Mexiko. Academy of Science, New York
Wasson RG (1962) The hallucinogenic mushrooms of Mexiko and psilocybin: a bibliography. Bot Mus Leafl Hary Univ 20: 20–73
Wasson RG (1968) Soma. Divine mushroom of immortality. Harcourt Brace Jovanovich New York
Wasson VP, Wasson RG (1957) Mushrooms, Russia and history. Pantheon, New York
Wasson RG, Hofman A, Ruck CAP (1978) The road to Eleusis: Unveiling the secrets of the mysteries. Harcourt Brace Jovanovich, New York
Wax RH, Wax ML (1962) The magical world view. J Sci Study Rel 1: 179–188
Wells B (1974) Psychedelic drugs. Penguin, Baltimore
Whites SC, Brin SC, Janicki BW (1975) Mitogen-induced blastogenic responses of lymphocytes from marihuana smokers. Science 188: 71–72
Williams EG, Himmelsbach CK, Wikler A, Ruble DC, Lloyd BJ Jr (1946) Studies on marijuana and parahexyl compound. Public Health Rep 61: 1059–1083
Winterfeldt E (1971) Neuere Aspekte in der Chemie der Indolalkaloide. Chimia 25: 394–396
Winterfeldt E (1974) Stereoselektive Totalsynthese von Indolalkaloiden. Fortschr Chem Org Naturst 31: 469–472
Woggon B (1974) Haschisch — Konsum und Wirkung. Springer, Berlin Heidelberg New York Yago KB, Pitts FN Jr., Burgoyne RW et al. (1981) The urban epidemic of phencyclidine (PCP) use. J Clin Psychiatry 42:193–196
Zellweger H, McDonald JS, Abbo G (1967) Is isoergicacid diethylamide a teratogen? Lancet 7525: 1066–1068
Zimmermann AM, Raj AY (1980) Influence of cannabinoids on somatic cells in vivo. Pharmacology 21: 277–287
Zimmerman S, Zimmerman AM, Cameron IL, Laurence HL (1977) Delta-9-tetrahydrocannabinol, cannabidiol, and cannabinol effects on the immune response of mice. Pharmacology 15: 10–23
Zschockelt A (1986) Die „nicht geringe Menge“ Cannabis — Problematik der THC-Bestimmung. MDR 6: 457–459
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Geschwinde, T. (1990). Psychodysleptika. In: Rauschdrogen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-09680-2_2
Download citation
DOI: https://doi.org/10.1007/978-3-662-09680-2_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-52662-9
Online ISBN: 978-3-662-09680-2
eBook Packages: Springer Book Archive